JPL Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
JPL Wealth Management's VRTX Position: Q2 2026 in Review
JPL Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 47% in Q2 2026, buying an estimated $25.3K and bringing the position to 179 shares worth $89K. The position accounts for 0.02% of the portfolio, ranked #185.
JPL Wealth Management first reported a position in VRTX in Q3 2025 and has held it in 3 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- JPL Wealth Management held 179 shares of Vertex Pharmaceuticals worth $89K as of Q2 2026.
- JPL Wealth Management bought 57 Vertex Pharmaceuticals shares in Q2 2026, an estimated $25.3K.
- Vertex Pharmaceuticals made up 0.02% of JPL Wealth Management's portfolio in Q2 2026, its #185 holding.
- JPL Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.